Pacturan, Roberta .

HRN: 06-66-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/31/2023
09/07/2023
IV
1.5gm
Q6H
Infected Wound
Waiting Final Action 
08/31/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2023
09/07/2023
IV
600mg
Q8H
Infected Wound
Waiting Final Action 
08/31/2023
MUPIROCIN 2%, 15G (TUBE)
08/31/2023
09/07/2023
TOPICAL
Apply Thinly
BID
Infected Wound
Waiting Final Action 
08/31/2023
CEFTAZIDIME 1GM (VIAL)
08/31/2023
09/07/2023
IV
1g
Q8hour
Infected Wound
Waiting Final Action 
09/03/2023
MUPIROCIN 2%, 15G (TUBE)
09/03/2023
09/09/2023
TOPICAL
Apply On Affected Areas
TID
Infected Wounds
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: